Salivary Electrostimulation in the Treatment of Radiation Therapy–Induced Xerostomia (LEONIDAS-2): A Multicenter, Randomized, Double-Masked, Sham-Controlled, Phase 3 Trial
International Journal of Radiation Oncology*Biology*Physics · 2024
DOI: 10.1016/j.ijrobp.2023.03.047 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2024. Verfasst von Valeria Mercadante und 10 weiteren Autor:innen. Beteiligte Einrichtung: Eastman Dental Institute, University College London, London, United Kingdom. Electronic address: v.mercadante@ucl.ac.uk. Hauptthemen laut MEDLINE: Xerostomia, Head and Neck Neoplasms, Radiation Injuries, Electric Stimulation Therapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Cancer Research UK, National Institute for Health and Care Research.
Abstract (Originalsprache)
PURPOSE: Radiation therapy-induced xerostomia significantly affects quality of life in head and neck cancer survivors. Neuro-electrostimulation of the salivary glands may safely increase natural salivation and reduce dry mouth symptoms. METHODS AND MATERIALS: This multicenter, double-masked, randomized, sham-controlled clinical trial assessed the long-term effects of a commercially available intraoral neuro-electrostimulating device in lessening xerostomia symptoms, increasing salivary flow, and improving quality of life in individuals with radiation therapy-induced xerostomia. Using a computer-generated randomization list, participants were assigned (1:1) to an active intraoral custom-made removable electrostimulating device or a sham device to be used for 12 months. The primary outcome was the proportion of patients reporting a 30% improvement on the xerostomia visual analog scale at 12 months. A number of secondary and exploratory outcomes were also assessed through validated measurements (sialometry and visual analog scale) and quality-of-life questionnaires (EORTC QLQ-H&N35, OH-QoL16, and SF-36). RESULTS: As per protocol, 86 participants were recruited. Intention-to-treat analyses showed no statistical evidence of a difference between the study groups with respect to the primary outcome or for any of the secondary clinical or quality-of-life outcomes. Exploratory analyses showed a statistically significant difference in the changes over time of the dry mouth subscale score of the EORTC QLQ-H&N35 in favor of the active intervention. CONCLUSIONS: LEONIDAS-2 did not meet the primary and secondary outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Eastman Dental Institute, University College London, London, United Kingdom. Electronic address: v.mercadante@ucl.ac.uk.
- Dental Services, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
- Maxillofacial Unit, Bradford Teaching Hospitals Foundation Trust and Bradford Institute for Health Research, Temple Bank House, Bradford Royal Infirmary, Bradford, United Kingdom.
- Royal Marsden NHS Foundation Trust, London, United Kingdom.
- Royal Marsden NHS Foundation Trust, London, United Kingdom; Institute of Cancer Research, London, United Kingdom.
- Department of Oncology, University College London NHS Foundation Trust, London, United Kingdom.
Förderung
- Cancer Research UK
- National Institute for Health and Care Research
Zitieren
APA
Mercadante, V., Hamad, A. A., McCaul, J., Nutting, C., Harrington, K., Carnell, D., Urbano, T. G., Kalavrezos, N., Barber, J. A., Porter, S. R., & Fedele, S. (2024). Salivary Electrostimulation in the Treatment of Radiation Therapy–Induced Xerostomia (LEONIDAS-2): A Multicenter, Randomized, Double-Masked, Sham-Controlled, Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2023.03.047
Vancouver
Mercadante V, Hamad AA, McCaul J, Nutting C, Harrington K, Carnell D, et al. Salivary Electrostimulation in the Treatment of Radiation Therapy–Induced Xerostomia (LEONIDAS-2): A Multicenter, Randomized, Double-Masked, Sham-Controlled, Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 2024. doi:10.1016/j.ijrobp.2023.03.047
BibTeX
@article{Mercadante2024,
author = {Mercadante, Valeria and Hamad, Arwa Al and McCaul, James and Nutting, Christopher and Harrington, Kevin and Carnell, Dawn and Urbano, Teresa Guerrero and Kalavrezos, Nicholas and Barber, Julie A and Porter, Stephen R and Fedele, Stefano},
title = {Salivary Electrostimulation in the Treatment of Radiation Therapy–Induced Xerostomia (LEONIDAS-2): A Multicenter, Randomized, Double-Masked, Sham-Controlled, Phase 3 Trial},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2024},
doi = {10.1016/j.ijrobp.2023.03.047}
}
EUVIMED